Global investment firm TPG has entered into a binding agreement to acquire a 35% stake in SCHOTT Poonawalla Pvt Ltd, a ...

TPG, a global alternative asset management firm, has entered into a binding agreement to acquire a 35% stake in SCHOTT ...

TPG acquires 35% stake in SCHOTT Poonawalla from Serum Institute of India; SCHOTT Pharma retains 50% while SII continues as ...

TPG will acquire a 35% stake in SCHOTT Poonawalla from the Serum Institute of India. This joint venture with SCHOTT Pharma is ...

Global alternative asset firm TPG has acquired a 35% stake in SCHOTT Poonawalla, a joint venture between SCHOTT Pharma and ...

TPG, a leading global alternative asset management firm will acquire 35% stake in SCHOTT Poonawalla from Serum Institute of India (SII) SII will retain a minority stake in the company, with SCHOTT ...

SCHOTT Pharma, a provider of drug containment solutions and delivery systems for injectable drugs, announced that TPG — a ...

TPG is acquiring a 35% stake in SCHOTT Poonawalla, a joint venture of SCHOTT Pharma and Serum Institute of India. The deal is ...

TPG Growth, TPG’s middle market and growth equity platform, is funding the investment, along with Novo Holdings as a ...

Global alternative asset management firm TPG has entered into a binding agreement to acquire a 35% stake in Schott Poonawalla ...

The transaction, funded through TPG Growth and co-investor Novo Holdings, is expected to close in the first half of 2025.

TPG has entered into a binding agreement to acquire 35% stake in Schott Poonawalla from Serum Institute of India (SII), said ...